ENTRY       D12439            Mixture   Drug
NAME        Sodium phenylbutyrate and taurursodiol;
            Relyvrio (TN)
PRODUCT     RELYVRIO (Amylyx Pharmaceuticals)
COMPONENT   Sodium phenylbutyrate [DR:D05868], (Taurursodiol [DR:D11836] | Taurursodiol dihydrate)
REMARK      Product: D12439<US>
EFFICACY    Neurodegenerative diseases agent
  DISEASE   Amyotrophic lateral sclerosis [DS:H00058]
BRITE       USP drug classification [BR:br08302]
             Central Nervous System Agents
              Amyotrophic Lateral Sclerosis (ALS) Agents
               Sodium phenylbutyrate/ Taurursodiol
                D12439  Sodium phenylbutyrate and taurursodiol
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D12439
///
